NCT04176055View on ClinicalTrials.gov

Treatment Strategies in CHS

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2022

Conditions
Cannabis Hyperemesis Syndrome
Interventions
DRUG

Haloperidol

haloperidol intervention

Trial Locations (1)

T2N 4N1

University of Calgary, Calgary

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Calgary

OTHER

NCT04176055 - Treatment Strategies in CHS | Biotech Hunter | Biotech Hunter